Early diagnosis of cancer remains a key goal in modern medicine. In many cases, early detection significantly increases the chances of successful treatment. However, traditional diagnostic methods often require complex procedures and are not always able to detect the disease in its early stages.
Researchers from Johns Hopkins University have proposed a new approach to detecting cancer using blood tests. The developed technology allows for the detection of disease signs without the need for complex interventions, making it more accessible and convenient for patients.
The method is based on a combination of DNA analysis and the detection of specific proteins associated with tumor processes. This integrated approach significantly improves diagnostic accuracy. The new test, called CancerSEEK, is capable of detecting several types of cancer from a single blood sample.
Clinical pathologies that this method can detect include stomach, liver, pancreatic, ovarian, esophageal, and breast cancers. This makes the technology particularly valuable, as many of these diseases are difficult to diagnose in their early stages using traditional methods.
In clinical trials, the new test demonstrated high accuracy. Studies involving over a thousand people successfully identified signs of the disease at early stages, which is particularly important for successful treatment. Furthermore, the procedure is faster than traditional diagnostic methods.
An additional advantage is the relative simplicity of the test. It does not require sophisticated equipment, meaning it could potentially be implemented into widespread medical practice. This opens the possibility of more widespread screening and increased access to early diagnosis.
Despite these encouraging results, research is ongoing. Scientists are striving to improve the accuracy of the method and expand the range of diseases it can detect. If the technology proves effective, it could significantly change the approach to cancer detection and treatment.
e-news.com.ua
